MIND Prize Initiative
The MIND Prize funds innovative neuroscience research on neurodegenerative diseases, supporting bold, interdisciplinary projects to advance understanding of the brain.
Funder: Pershing Square Philanthropies
Due Dates (Anticipated): September 2026: Letter of Intent deadline (projected)
Funding Amounts: $750,000 total per award ($250,000/year for 3 years); at least 6 prizes awarded annually
Summary: Supports innovative neuroscience research to advance understanding of the brain and neurodegenerative diseases.
Key Information: For early-to-mid-career investigators at U.S. academic institutions; interdisciplinary and high-risk research encouraged.
Description
The MIND Prize Initiative, funded by Pershing Square Philanthropies, accelerates transformative research in neuroscience, particularly on neurodegenerative diseases (NDDs) such as Alzheimer’s and dementia. The prize is designed to empower early-to-mid-career investigators to pursue bold, interdisciplinary projects that challenge conventional paradigms and foster novel approaches. Supported research spans fundamental brain science, brain mapping, neurobiology, machine learning, drug delivery, and synthetic biology, among other areas. Awardees join a network of innovative scientists and gain access to unique networking, collaboration, and professional development opportunities.
